Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia. | Clin Cancer Res | 2006 | 3.47 |